Document is current
Any future updates will be listed below
-
Authors
Baek, Amy E.
Yu, Yen-Rei A.
He, Sisi
Wardell, Suzanne E.
Chang, Ching-Yi
Kwon, Sanghoon
Pillai, Ruchita V.
McDowell, Hannah B.
Thompson, J. Will
Dubois, Laura G.
Sullivan, Patrick M.
Kemper, Jongsook K.
Gunn, Michael D. https://orcid.org/0000-0003-4602-0667
McDonnell, Donald P.
Nelson, Erik R. https://orcid.org/0000-0002-8887-1905
- License Information
-
More Information
Article History
Received: 23 September 2016
Accepted: 7 August 2017
First Online: 11 October 2017
Competing interests
: E.R.N. and D.P.M. have applied for a patent covering the use of CYP27A1 inhibitors, statins, or LXR antagonists alone or in combination with conventional therapy for the treatment of breast cancer. Title: “Use of cyp27a1 inhibitors, statin, or lxr antagonists alone or in combination with conventional therapy for the treatment of breast cancer”. Inventors: D.P.M. and E.R.N. Applicant: Duke University. Filing Date: Jan. 3, 2014. Application Number: PCT/US2014/010179. The remaining authors declare no competing financial interests.
